IMMUNOHISTOCHEMISTRY EPIDERMAL GROWTH FACTOR RECEPTOR EGFR Test
Test Name: IMMUNOHISTOCHEMISTRY EPIDERMAL GROWTH FACTOR RECEPTOR EGFR Test
Components: Immunohistochemistry
Price: 500.0 AED
Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery: Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex: 7 days
Test Type: Cancer
Doctor: Oncologist, Pathologist
Test Department: DNA Labs UAE
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details
The immunohistochemistry (IHC) test for the epidermal growth factor receptor (EGFR) is a diagnostic tool used to detect the presence and activity of EGFR in tissue samples. EGFR is a protein that plays a crucial role in cell growth and division, and its overexpression or mutation is often associated with various types of cancer, particularly lung cancer.
The IHC test involves the use of specific antibodies that bind to EGFR proteins in the tissue sample. These antibodies are labeled with a colored or fluorescent marker, which allows for the visualization and quantification of EGFR expression under a microscope. The intensity and distribution of the staining can provide valuable information about the activity and localization of EGFR in the tissue.
The EGFR IHC test is commonly used in clinical settings to determine the eligibility of patients for targeted therapies, such as EGFR inhibitors. It helps identify patients who are likely to benefit from these treatments and can also provide prognostic information for disease progression and response to therapy.
Overall, the EGFR IHC test is a valuable tool in cancer diagnosis and treatment decision-making, as it provides important information about the presence and activity of EGFR in tissue samples.
| Test Name | IMMUNOHISTOCHEMISTRY EPIDERMAL GROWTH FACTOR RECEPTOR EGFR Test |
|---|---|
| Components | |
| Price | 500.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; ReportBlock: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist, Pathologist |
| Test Department: | |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details |
The immunohistochemistry (IHC) test for the epidermal growth factor receptor (EGFR) is a diagnostic tool used to detect the presence and activity of EGFR in tissue samples. EGFR is a protein that plays a crucial role in cell growth and division, and its overexpression or mutation is often associated with various types of cancer, particularly lung cancer. The IHC test involves the use of specific antibodies that bind to EGFR proteins in the tissue sample. These antibodies are labeled with a colored or fluorescent marker, which allows for the visualization and quantification of EGFR expression under a microscope. The intensity and distribution of the staining can provide valuable information about the activity and localization of EGFR in the tissue. The EGFR IHC test is commonly used in clinical settings to determine the eligibility of patients for targeted therapies, such as EGFR inhibitors. It helps identify patients who are likely to benefit from these treatments and can also provide prognostic information for disease progression and response to therapy. Overall, the EGFR IHC test is a valuable tool in cancer diagnosis and treatment decision-making, as it provides important information about the presence and activity of EGFR in tissue samples. |
